This Cytek Biosciences Insider Increased Their Holding By 169% Last Year [Yahoo! Finance]
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: Yahoo! Finance
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In the last twelve months, the biggest single purchase by an insider was when Chief Financial Officer William McCombe bought US$97k worth of shares at a price of US$2.78 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$5.00. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction! View our latest analysis for Cytek Biosciences There are always plent
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue ResultsGlobeNewswire
- Cytek Biosciences (NASDAQ:CTKB) had its price target raised by analysts at TD Cowen from $4.00 to $5.00. They now have a "buy" rating on the stock.MarketBeat
- Cytek Biosciences (NASDAQ:CTKB) had its "buy" rating reaffirmed by analysts at Cowen Inc.MarketBeat
- Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.MarketBeat
CTKB
Earnings
- 11/5/25 - Beat
CTKB
Sec Filings
- 1/13/26 - Form 8-K
- 11/20/25 - Form 4
- 11/20/25 - Form 4
- CTKB's page on the SEC website